Jan 13, 2020 / 05:00PM GMT
Robert Justin Marcus - JP Morgan Chase & Co, Research Division - Analyst
Good morning, everyone. Welcome to the JPMorgan Healthcare Conference. I'm Robbie Marcus, the medtech analyst here. I'm very happy to have Medtronic presenting this morning. And warm welcome to Omar Ishrak, the Chairman and CEO. Omar?
Omar S. Ishrak - Medtronic plc - Chairman & CEO
Thanks, Robbie. And I'm only Chairman and CEO for the next 3 months, I think. But it's great to be here and talk to you. This is going to be my last presentation at the JPMorgan, but it's been a real pleasure talking to this group and everything that we've learned from you. But the most important thing is that I remain as excited as ever about Medtronic and where it can go in the future, and I'd love to share where we stand today and why I'm so excited about it.
First, the forward-looking statements. I mean, this is in our website. So please take a look if you need to, but I'm going to move on.
This is a background on Medtronic, and I think most of you know this. But really, I want to
Medtronic PLC at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot